Home
>
National Drug Code (NDC)
>
Fenofibrate
Fenofibrate - 68180-131-06 - (fenofibrate)
Drug Information of Fenofibrate
| Product NDC: | 68180-131 |
| Proprietary Name: | Fenofibrate |
| Non Proprietary Name: | fenofibrate |
| Active Ingredient(s): | 130 mg/1 & nbsp; fenofibrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fenofibrate
| Product NDC: | 68180-131 |
| Labeler Name: | Lupin Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021695 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 20130222 |
Package Information of Fenofibrate
| Package NDC: | 68180-131-06 |
| Package Description: | 30 CAPSULE in 1 BOTTLE (68180-131-06) |
NDC Information of Fenofibrate
| NDC Code | 68180-131-06 |
| Proprietary Name | Fenofibrate |
| Package Description | 30 CAPSULE in 1 BOTTLE (68180-131-06) |
| Product NDC | 68180-131 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | fenofibrate |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20130222 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Lupin Pharmaceuticals, Inc. |
| Substance Name | FENOFIBRATE |
| Strength Number | 130 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator-activated Receptor alpha Agonists [MoA],PPAR alpha [Chemical/Ingredient] |
